Literature DB >> 31446745

Potential Vaccines for Treating Crohn's Disease

Mohammad Rostami-Nejad1, Mohammad Hossein Yazdi2,3, Shekoufeh Nikfar3,4, Ali Rezaie5, Mohammad Abdollahi3,6.   

Abstract

Crohn's disease (CD) is an inflammatory disease of the gastrointestinal tract (GIT) and can affect several parts of the digestive system. There is a relationship between impaired mucosal barrier in the GIT of inflammatory bowel disease patients and the role of bacteria such as Mycobacterium avium in CD. Apart from different therapeutic approaches for treating CD, development of a vaccine is a novel modality. In the present article, most available therapeutic opportunities in the last decade, especially the possibility of vaccines against CD, are reviewed. According to the search, availability of a new generation of vaccines against CD is expected specially tolerogenic ex vivo-derived DC-based vaccines. Regarding different locations of the challenge and the variety of clinical manifests of CD and also the type of resident antigen-presenting cells and their traffic in different parts of GIT, the results of immunotherapy with DC-based vaccines may vary case by case.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel diseases; Vaccines

Mesh:

Substances:

Year:  2019        PMID: 31446745

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  2 in total

1.  Introducing GATA3 as a prominent player in Crohn's disease.

Authors:  Sina Rezaei-Tavirani; Nastaran Asri; MohammadAli Emamhadi; Somayeh Jahani-Sherafat; Ali Seyed Salehi; Zahra Gholamrezaei; Elena Lak
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

2.  COVID-19 vaccines: ethical framework concerning human challenge studies.

Authors:  Daniela Calina; Thomas Hartung; Anca Oana Docea; Demetrios A Spandidos; Alex M Egorov; Michael I Shtilman; Felix Carvalho; Aristidis Tsatsakis
Journal:  Daru       Date:  2020-08-27       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.